1. THU0045 Epratuzumab, an Antibody Targeting CD22 on B Cells, Induces Phosphoprotein Changes Following B-Cell Receptor Activation in Vitro. (23rd January 2014) Authors: Lumb, S.; Torbett, N.; Vendrell, I.; Turner, H.; Page, M.; Hales, P.; Maloney, A.; Vanhaesebroeck, B.; Cutillas, P.; Shock, A. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment of Cancer Pain by Targeting Cytokines. (11th October 2015) Authors: Vendrell, I.; Macedo, D.; Alho, I.; Dionísio, M. R.; Costa, L. Other Names: Song Xue-Jun Academic Editor. Journal: Mediators of inflammation Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗